Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Bioadaptives (BDPT) Revenue (2019 - 2025)

Bioadaptives' Revenue history spans 7 years, with the latest figure at $4632.0 for Q3 2025.

  • For Q3 2025, Revenue changed N/A year-over-year to $4632.0; the TTM value through Sep 2025 reached $7851.0, down 60.49%, while the annual FY2024 figure was $12669.0, 55.65% down from the prior year.
  • Revenue for Q3 2025 was $4632.0 at Bioadaptives, up from $3219.0 in the prior quarter.
  • Across five years, Revenue topped out at $15649.0 in Q3 2023 and bottomed at $675.0 in Q2 2024.
  • The 5-year median for Revenue is $4420.0 (2021), against an average of $5377.3.
  • The largest annual shift saw Revenue crashed 71.14% in 2024 before it skyrocketed 376.89% in 2025.
  • A 5-year view of Revenue shows it stood at $3851.0 in 2021, then increased by 3.45% to $3984.0 in 2022, then skyrocketed by 80.75% to $7201.0 in 2023, then crashed by 90.63% to $675.0 in 2024, then soared by 586.22% to $4632.0 in 2025.
  • Per Business Quant, the three most recent readings for BDPT's Revenue are $4632.0 (Q3 2025), $3219.0 (Q2 2025), and $675.0 (Q2 2024).